Select Page


CanAscen Group


The CanAscen Group Inc. (“CAG”) is a federally incorporated Canadian company based in Vancouver, British Columbia. CAG was formed in 2017 to develop and produce innovative premium cannabis and cannabinoid-based products. CAG’s wholly owned operating subsidiary, New Life Botanicals Inc. (“NLB”) is located on 40 acres in St. Anne, Manitoba, NLB and is currently at the confirmation of readiness stage with Health Canada for its ACMPR Licensed Producer designation.  

CAG intends to produce leading consumer brands that target the ultra-premium and premium segments of the Canadian cannabis market.  CAG will leverage the cannabis manufacturing expertise, specialized genetics portfolio, and established brand reputation of seasoned, global corporate partners to help drive CAG’s success in Canada.  CAG’s cannabis products will be founded on high-quality, consistent, and differentiated genetics. CAG is constructing a 39,000 square foot indoor production facility in St. Anne.

In addition to the premium cultivation platform being developed, CAG possesses a unique portfolio of proprietary cannabis and hemp-derived CBD extraction technologies, including a proprietary method to convert of hemp-derived cannabidiol (CBD) into tetrahydrocannabinol (THC). CAG will leverage its technology and provide services to produce unique cannabinoid-based ingredients and differentiated consumer products for the Canadian cannabis market.  CAG’s cannabinoid-based products will span edibles, beverages, topicals, cosmetics, and nutraceuticals and are expected to be available in the market in early 2020.